Details for New Drug Application (NDA): 216967
✉ Email this page to a colleague
The generic ingredient in MESALAMINE is mesalamine. There are twenty-eight drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the mesalamine profile page.
Summary for 216967
Tradename: | MESALAMINE |
Applicant: | Alembic |
Ingredient: | mesalamine |
Patents: | 0 |
Suppliers and Packaging for NDA: 216967
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MESALAMINE | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 216967 | ANDA | Alembic Pharmaceuticals Limited | 46708-724 | 46708-724-35 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46708-724-35) |
MESALAMINE | mesalamine | CAPSULE, EXTENDED RELEASE;ORAL | 216967 | ANDA | Alembic Pharmaceuticals Limited | 46708-724 | 46708-724-91 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46708-724-91) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 375MG | ||||
Approval Date: | Oct 28, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription